AMBEA Ambea AB (publ)

19.03USD193.30 SEK · STO+0.62%Mkt Cap: 1.59B USDP/E: 18.41

Ambea AB (publ) provides elderly care, disability care, and psychosocial support for the elderly and people with disabilities in Sweden, Norway, and Denmark. It operates through Nytida, Vardaga, Stendi, Altiden, and Klar…

Key Statistics

Company
Market Cap1.59B USD
Enterprise Value2.78B USD
Revenue (TTM)1.70B USD
Gross Profit1.52B USD
Net Income (TTM)65.46M USD
Revenue/Share21.11 USD
Last Price19.03 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees41.0K
CountrySE
SectorHealthcare
IndustryMedical Care Facilities
ISINSE0009663826
Valuation
P/E (Trailing)18.41
P/E (Forward)22.90
PEG—
EV/EBITDA16.16
EV/Revenue1.63
P/S0.93
P/B3.12
EPS (TTM)1.03 USD
EPS (Forward)0.83 USD
52W Range
11.0995% of range19.44
52W High19.44 USD
52W Low11.09 USD
Profitability
Gross Margin96.53%
Oper. Margin8.85%
EBITDA Margin10.10%
Profit Margin4.15%
ROE12.79%
ROA3.25%
ROIC5.94%
ROCE8.55%
Growth
Revenue Growth8.10%
Earnings Growth27.20%
Cash Flow & Leverage
Operating CF213.49M USD
CapEx (TTM)13.68M USD
FCF Margin13.65%
FCF Yield14.66%
Net Debt1.36B USD
Net Debt/EBITDA7.90
Net Debt/FCF5.84
Balance Sheet
Debt/Equity2.43
Current Ratio0.40
Quick Ratio0.36
Book Value/Sh6.10 USD
Cash/Share0.02 USD
Dividends
Fwd Div Rate0.26 USD
Trail. Div Rate0.26 USD
Div. Yield1.38%
5Y Avg Yield2.02%
Payout Ratio25.26%
Ex-Div DateMay 13, 2026
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)21.92 USD
Upside (mean)+15.2%
Target Range20.97 USD – 23.13 USD
20.97+15.2% to mean23.13
# Analysts3
Ownership
Shares Out.83.47M
Float72.05M
Insiders2.67%
Institutions54.78%
Technical
SMA 5017.84 (+6.6%)
SMA 20014.92 (+27.5%)
Beta0.65
S&P 52W Chg12.00%
Avg Vol (30d)153.27K
Avg Vol (10d)173.88K
Technical Indicators
RSI (14)60.7
MACD3.8834
MACD Signal4.0401
MACD Hist.-0.1567
BB Upper19.63 USD
BB Middle18.65 USD
BB Lower17.68 USD
BB Width10.47%
ATR (14)0.4252 USD
Vol Ratio (20d)0.66x

About Ambea (STO: AMBEA)

›

Ambea (STO: AMBEA) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 41,000 employees.

The shares were at 193.30 SEK on 19 November 2026, up 51.7% over 52 weeks. Its 52-week range is 112.70 SEK to 197.50 SEK: the price is 2.1% below the high and 71.5% above the low.

At a market capitalisation of 16.13B SEK, it trades at 18.4 times trailing earnings and 22.9 times forward earnings. The median trailing P/E of its 18 largest Medical Care Facilities peers is 23.7, a discount of 22% for AMBEA. It pays a dividend yielding 1.38% (it pays out 25% of its earnings), against a median of 0.75% among the dividend payers in that peer group.

Ambea reports return on equity of 12.8%, an operating margin of 8.8% and revenue up 8.1% year over year.

Its debt exceeds its cash by 13.82B SEK, a debt-to-equity ratio of 2.43. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 3 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 222.67 SEK is 15.2% above the current price. The next earnings report is expected on 11 February 2027.